Clinical and genetic diagnosis of autosomal dominant osteopetrosis type II in a Chinese family: A case report

被引:2
|
作者
Gong, Hong-Ping [1 ,2 ]
Ren, Yan [2 ]
Zha, Pan-Pan [2 ]
Zhang, Wen-Yan [3 ]
Zhang, Jin [4 ]
Zhang, Zhi-Wen [4 ]
Wang, Chun [2 ,5 ]
机构
[1] Sichuan Univ, West China Hosp, Int Med Ctr Ward, Gen Practice Med Ctr, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, Chengdu 610041, Sichuan, Peoples R China
[3] Sichuan Univ, West China Hosp, Dept Pathol, Chengdu 610041, Sichuan, Peoples R China
[4] Peoples Hosp Leshan, Dept Endocrinol & Metab, Leshan 614003, Sichuan, Peoples R China
[5] Sichuan Univ, West China Hosp, Dept Endocrinol & Metab, 37 Guoxue Lane, Chengdu 610041, Sichuan, Peoples R China
关键词
Osteopetrosis; Autosomal dominant osteopetrosis type II; Diagnosis; Genetic analysis; Case report; MUTATIONS; LEADS;
D O I
10.12998/wjcc.v11.i3.700
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUNDOsteopetrosis is a rare genetic disorder characterized by increased bone density due to defective bone resorption of osteoclasts. Approximately, 80% of autosomal dominant osteopetrosis type II (ADO-II) patients were usually affected by heterozygous dominant mutations in the chloride voltage-gated channel 7 (ClCN7) gene and present early-onset osteoarthritis or recurrent fractures. In this study, we report a case of persistent joint pain without bone injury or underlying history. CASE SUMMARYWe report a 53-year-old female with joint pain who was accidentally diagnosed with ADO-II. The clinical diagnosis was based on increased bone density and typical radiographic features. Two heterozygous mutations in the ClCN7 and T-cell immune regulator 1 (TCIRG1) genes by whole exome sequencing were identified in the patient and her daughter. The missense mutation (c.857G > A) occurred in the CLCN7 gene p. R286Q, which is highly conserved across species. The TCIRG1 gene point mutation (c.714-20G > A) in intron 7 (near the splicing site of exon 7) had no effect on subsequent transcription. CONCLUSIONThis ADO-II case had a pathogenic CLCN7 mutation and late onset without the usual clinical symptoms. For the diagnosis and assessment of the prognosis for osteopetrosis, genetic analysis is advised.
引用
收藏
页码:700 / 708
页数:9
相关论文
共 50 条
  • [31] Bone Marrow Transplantation as a Therapy for Autosomal Dominant Osteopetrosis Type II in Mice
    Alam, Imranul
    Imel, Erik
    Gerard-O'Riley, Rita
    Acton, Dena
    Oakes, Dana
    Alvarez, Marta
    Kacena, Melissa
    Econs, Michael
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 303 - 303
  • [32] Potential therapeutic response in a severe case of autosomal dominant osteopetrosis type I
    Jafri, Syed Maisam
    Burke, Elizabeth A.
    Adams, David R.
    Evans, Colleen
    Bulas, Dorothy
    Weinerman, Stuart A.
    Pan, Kristen
    Collins, Michael T.
    Markello, Thomas C.
    Vezina, Gilbert
    Gahl, William A.
    Toro, Camilo
    JOURNAL OF TRANSLATIONAL GENETICS AND GENOMICS, 2022, 6 (02) : 281 - 289
  • [33] Type II autosomal dominant osteopetrosis (Albers-Schonberg disease):: Clinical and radiological manifestations in 42 patients
    Bénichou, OD
    Laredo, JD
    De Vernejoul, MC
    BONE, 2000, 26 (01) : 87 - 93
  • [34] Radiographic type I autosomal dominant osteopetrosis with syringohydromyelia
    Sari, A
    Demirci, A
    NEURORADIOLOGY, 1996, 38 (06) : 532 - 533
  • [35] ELEVATED SERUM LEVELS OF CREATINE KINASE-BB IN AUTOSOMAL DOMINANT OSTEOPETROSIS TYPE-II - A FAMILY STUDY
    YONEYAMA, T
    FOWLER, HL
    PENDLETON, JW
    SFORZA, PP
    GERARD, RD
    LUI, CY
    ELDRIDGE, TH
    IRANMANESH, A
    CLINICAL GENETICS, 1992, 42 (01) : 39 - 42
  • [36] Natural History of Type II Autosomal Dominant Osteopetrosis: A Single Center Retrospective Study
    Wang, Ziyuan
    Li, Xiang
    Wang, Ya
    Fu, Wenzhen
    Liu, Yujuan
    Zhang, Zhenlin
    Wang, Chun
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [37] Bone mineral density and laboratory evaluation of a type II autosomal dominant osteopetrosis carrier
    Takacs, I
    Cooper, H
    Weaver, DD
    Econs, MJ
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1999, 85 (01): : 9 - 12
  • [38] AUTOSOMAL DOMINANT OSTEOPETROSIS TYPE-II WITH MALIGNANT PRESENTATION - FURTHER SUPPORT FOR HETEROGENEITY
    WALPOLE, IR
    NICOLL, A
    GOLDBLATT, J
    CLINICAL GENETICS, 1990, 38 (04) : 257 - 263
  • [39] Clinical Significance of DXA and HR-pQCT in Autosomal Dominant Osteopetrosis (ADO II)
    Butscheidt, Sebastian
    Rolvien, Tim
    Kornak, Uwe
    Schmidt, Felix N.
    Schinke, Thorsten
    Amling, Michael
    Oheim, Ralf
    CALCIFIED TISSUE INTERNATIONAL, 2018, 102 (01) : 41 - 52
  • [40] Clinical Significance of DXA and HR-pQCT in Autosomal Dominant Osteopetrosis (ADO II)
    Sebastian Butscheidt
    Tim Rolvien
    Uwe Kornak
    Felix N. Schmidt
    Thorsten Schinke
    Michael Amling
    Ralf Oheim
    Calcified Tissue International, 2018, 102 : 41 - 52